Replimune Group, Inc.

REPL · NASDAQ
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Market Cap$785,499$514,585$1,028,042$886,564
- Cash$111,119$74,457$146,590$105,948
+ Debt$76,165$75,869$60,759$32,839
Enterprise Value$750,545$515,997$942,211$813,455
Revenue$0$0$0$0
% Growth
Gross Profit$0$0$0-$4,575
% Margin
EBITDA-$253,924-$227,770-$171,719-$114,408
% Margin
Net Income-$247,297-$215,794-$174,284-$118,036
% Margin
EPS Diluted-3.07-3.24-2.99-2.26
% Growth5.2%-8.4%-32.3%
Operating Cash Flow-$192,250-$185,467-$128,050-$82,180
Capital Expenditures-$6,687-$5,662-$2,270-$2,336
Free Cash Flow-$198,937-$191,129-$130,320-$84,516
Replimune Group, Inc. (REPL) Financial Statements & Key Stats | AlphaPilot